Recorded Chinese product: 盐酸罂粟碱注射液盐酸罂粟碱注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

罂粟碱 其辅料为乙二胺四乙酸二钠是一种在国家药监局注册认定的药品。该药品含有注射用水-4ef6f8fd等成分。

该药品关联的活性成分包括:注射用水。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:江苏恒瑞医药股份有限公司Chinese legal name: 江苏恒瑞医药股份有限公司。

您可以探索含有相同成分的其他药品:注射用水-4ef6f8fd成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 盐酸罂粟碱注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Manufacturers recorded for this product: 江苏恒瑞医药股份有限公司Chinese legal name: 江苏恒瑞医药股份有限公司.

Explore other medicines containing the same ingredient: products containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 盐酸罂粟碱注射液Recorded Chinese product: 盐酸罂粟碱注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 1ml∶30mg1 mL∶30 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 江苏恒瑞医药股份有限公司Chinese legal name: 江苏恒瑞医药股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H32020967

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H32020967

Manufacturer

Chinese legal name: 江苏恒瑞医药股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H32020967

生产企业

江苏恒瑞医药股份有限公司(国产)

适应症

本品用于治疗脑、心及外周血管痉挛所致的缺血,肾、胆或胃肠道等内脏痉挛。

用法用量

成人常用量。 1.肌内注射,一次30mg(1支),一日90~120mg(3-4支)。 2.静脉注射,一次30~120mg(1-4支),每。小时1次,应缓慢注射,不少于1~2分钟,以免发生心律失常以及足以致命的窒息等。用于心搏停止时,两次给药要相隔10分钟。

不良反应

1.用药后出现黄疸,眼及皮肤明显黄染,提示肝功能受损。
2.胃肠道外给药可引起注射部位发红、肿胀或疼痛。快速胃肠道外给药可使呼吸加深、面色潮红、心跳加速、低血压伴眩晕。
3.过量时可有视力模糊、复视、嗜睡或(和)软弱。

禁忌

完全性房室传导阻滞时禁用。震颤麻痹(帕金森氏病)时一般禁用。出现肝功能不全时应即行停药。

注意事项

1.对诊断的干扰:服药时血嗜酸性细胞、丙氨酸氨基转移酶、碱性磷酸酶、门冬氨酸氨基转移酶及胆红素可增高,提示肝功能受损.
2.由于对脑及冠状血管的作用不及对周围血管,可使中枢神经缺血区的血流进一步减少,出现"窃流现象",用于心绞痛、新近心肌梗死或卒中时须谨慎.
3.心肌抑制时忌大量,以免引起进一步抑制.
4.青光眼患者要定期检查眼压.
5.静脉注射大量能抑制房室和室内传导,并产生严重心律失常.
6.需注意定期检查肝功能,尤其是患者有胃肠道症状或黄疸时.出现肝功能不全时应停药.

贮藏

遮光,密封保存。

规格

1ml∶30mg

证据Evidence

  • 批准文号: 国药准字H32020967
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.